Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation

Endocrinology

Volumn 139, Issue 4, 1998, Pages 1981-1990

  Duan, Renqin ^a   Porter, Weston ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; HYDROXYTAMOXIFEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PALINDROMIC DNA;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DNA FLANKING REGION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REPORTER GENE;

EID: 0031791649     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.4.5870     Document Type: Article

References (41)

1. Curran T 1988 The fos oncogene. In: Reddy EP, Skalka AM, Curran T (eds) The Oncogene Handbook. Elsevier, Amsterdam, pp 307-325
2. Muller R 1986 Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. Biochim Biophys Acta 823:207-225
3. Cohen DR, Curran T 1989 The structure and function of the fos proto-oncogene. Crit Rev Oncogen 1:65-88
4. Curran T, Franza Jr BR 1988 Fos and jun: the AP-1 connection. Cell 55:395-397
5. Ginty DD, Bonni A, Greenberg ME 1994 Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77:713-725
6. Rivera VM, Greenberg ME 1990 Growth factor-induced gene expression: the ups and downs of c-fos regulation. New Biol 2:751-758
7. Rivera VM, Sheng M, Greenberg ME 1990 The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev 4:255-268
8. Fisch TM, Prywes R, Roeder RG 1987 c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Mol Cell Biol 7:3490-3502
9. Shaw PE, Schroter H, Nordheim A 1989 The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56:563-572
10. Treisman R 1986 Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46:567-574
11. Candeliere GA, Prud'homme J, St-Amaud R 1991 Differential stimulation of Fos and Jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 5:1780-1788
12. Lee K, Deeds JD, Chiba S, Un-No M, Bond AT, Segre GV 1994 Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134:441-450
13. McDonnell SE, Kerr LD, Matrisian LM 1990 Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of protooncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 10:4284-4293
14. Hill CS, Treisman R 1995 Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J 14:5037-5047
15. Wilding G, Lippman ME, Gelmann EP 1988 Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res 48:802-805
16. Weisz A, Bresciani F 1993 Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit Rev Oncog 4:361-388
17. Van der Burg B, De Groot RP, Isbrücker L, Kruijer W, De Laat SW 1990 Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells. Mol Endocrinol 4:1720-1726
18. Van der Burg B, Van Selm-Miltenburg AJP, De Laat SW, Van Zoelen EJJ 1989 Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 64:223-228
19. Bonapace IM, Addeo R, Altucci L, Cicatiello L, Bifulco M, Laezza C, Salzano S, Sica V, Bresciani F, Weisz A 1996 17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation. Oncogene 12:753-763
20. Van der Burg B, De Groot RP, Isbrucker L, Kruijer W, De Laat SW 1991 Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells. J Steroid Biochem Mol Biol 40:215-221
21. Doucas V, Spyrou G, Yaniv M 1991 Unregulated expression of c-Jun and c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer-derived cells. EMBO J 10:2237-2245
22. Shemshedini L, Knauthe R, Sassone-Corsi P, Pornon A, Gronemeyer H 1991 Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J 10:3839-3849
23. Tzukerman M, Zhang X, Pfahl M 1991 Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanylphorbol-13-acetate: a molecular analysis. Mol Endocrinol 5:1983-1992
24. Gaub M, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P 1990 Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell 63:1267-1276
25. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
26. Webb P, Lopez GN, Uht RM, Kuchner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
27. Weisz A, Rosales R 1990 Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18:5097-5106
28. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
29. Krishnan V, Porter W, Santostefano M, Wang X, Safe S 1995 Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 23,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol Cell Biol 15:6710-6719
30. Krishnan V, Wang X, Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917
31. Porter W, Wang F, Wang W, Duan R, Safe S 1996 Role of estrogen receptor/ Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10:1371-1378
32. Ponglikitmongkol M, White JH, Chambon P 1990 Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. EMBO J 9:2221-2231
33. Dubik D, Shiu RPC 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594
34. Wu-Peng XS, Pugliese TE, Dickerson HW, Pentecost BT 1992 Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol Endocrinol 6:231-240
35. Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA 1995 Estradiol regulation of the human retinoic acid receptor a gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999-5006
36. Miltenberger RJ, Famham RJ, Smith DE, Stommel JM, Comwell MM 1995 v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. Cell Growth Differ 6:549-556
37. Wagner SA, Green MR 1993 HTLV-1 Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 266:395-399
38. Sanchez HB, Yieh L, Osborne TF 1995 Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J Biol Chem 270:1161-1169
39. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ 1997 CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415
40. Maas RA, Bruning PF, Top B, Breedijk AJ, Peterse HL 1995 Growth arrest associated changes of mRNA levels in breast cancer cells measured by semiquantitative RT-PCR: potential early indicators of treatment response. Cancer Lett 97:107-116
41. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131